Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of ACU-4429 in geographic atrophy due to dry age-related macular degene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• ACU-4429

Snippet

Sponsor: Kubota Vision Inc. | Conditions: Dry Age-related Macular Degeneration, Geographic Atrophy | Phase 2 | Status: COMPLETED